Biocon Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 600.30 | 600.30 | 600.30 | 600.00 | 600.00 |
Reserves | 10,312.00 | 10,315.70 | 7,492.60 | 7,307.10 | 6,937.30 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 10,912.30 | 10,916.00 | 8,092.90 | 7,907.10 | 7,537.30 |
Secured Loans | 2,040.80 | 1,297.70 | 75.90 | 0.00 | 0.00 |
Unsecured Loans | 2.00 | 3.50 | 1.00 | 3.10 | 4.00 |
Total Debt | 2,042.80 | 1,301.20 | 76.90 | 3.10 | 4.00 |
Other Liabilities | 123.20 | 116.00 | 109.20 | 115.20 | 42.20 |
Total Liabilities | 13,078.30 | 12,333.20 | 8,279.00 | 8,025.40 | 7,583.50 |
APPLICATION OF FUNDS : | |||||
Gross Block | 2,586.80 | 2,479.70 | 2,269.70 | 2,098.10 | 1,993.30 |
Less: Accumulated Depreciation | 1,628.40 | 1,518.30 | 1,399.50 | 1,300.00 | 1,200.10 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 958.40 | 961.40 | 870.20 | 798.10 | 793.20 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 559.60 | 343.50 | 284.90 | 179.20 | 151.90 |
Investments | 9,318.50 | 9,270.70 | 5,280.00 | 5,412.70 | 4,952.80 |
Current Assets, Loans & Advances | |||||
Inventories | 664.70 | 560.10 | 541.50 | 430.90 | 534.70 |
Sundry Debtors | 1,048.10 | 658.00 | 700.60 | 605.40 | 573.20 |
Cash and Bank Balance | 585.70 | 720.30 | 689.30 | 601.20 | 375.30 |
Loans and Advances | 398.60 | 306.70 | 208.60 | 192.50 | 461.70 |
Total Current Assets | 2,697.10 | 2,245.10 | 2,140.00 | 1,830.00 | 1,944.90 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 556.80 | 571.30 | 474.30 | 435.60 | 618.10 |
Provisions | 133.10 | 125.40 | 115.70 | 112.70 | 109.20 |
Total CL & Provisions | 689.90 | 696.70 | 590.00 | 548.30 | 727.30 |
Net Current Assets | 2,007.20 | 1,548.40 | 1,550.00 | 1,281.70 | 1,217.60 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 37.00 | 44.90 | 159.60 | 195.40 | 226.30 |
Deferred Tax Liability | 29.60 | 22.10 | 39.60 | 49.00 | 46.80 |
Net Deferred Tax | 7.40 | 22.80 | 120.00 | 146.40 | 179.50 |
Other Assets | 227.20 | 186.40 | 173.90 | 207.30 | 288.50 |
Total Assets | 13,078.30 | 12,333.20 | 8,279.00 | 8,025.40 | 7,583.50 |
Contingent Liabilities | 911.60 | 681.70 | 525.70 | 1,574.90 | 2,225.80 |